PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

WHO decision leaflet cuts inappropriate antibiotic use in simulation

antibioticsantimicrobial stewardshipdelayed prescribingdecision support toolantimicrobial resistancebehavioral experimentprimary careWHO leafletrandomized experimentpatient decision aid Infectious Disease / Antimicrobials

Background Information

Decision support reduces inappropriate antibiotic use effectively.

Overprescribing antibiotics in primary care contributes to antimicrobial resistance. Decision support tools reduced inappropriate antibiotic use for viral infections in all tested conditions (p < .001). Incorporating decision support into delayed prescriptions can reduce unnecessary antibiotic use, promoting better antimicrobial stewardship. Decision support tools improve responsible antibiotic use in delayed prescription settings.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Sievert EDC, Gross R, Korn L, Betsch C, Böhm R

Citation: Sievert EDC, Gross R, Korn L, et al. Using a decision support tool to reduce inappropriate antibiotic use after a delayed prescription. Applied psychology. Health and well-being. 2026;18(4):e70198. doi:10.1111/aphw.70198

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.